HBT1 CAS No.：489408-02-8 99.0 % Purity min. For nootropics enhance learning ability.

1. Product introduction

BT1 binds to the ligand-binding domain of the α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptor (AMPA-R) in a glutamate-dependent manner. This means that HBT1 is a molecule that can only bind to a specific site on the AMPA-R protein when glutamate is present, and this binding helps regulate the activity of the protein.  AMPA receptors are expressed throughout the central nervous system and play important roles in neuronal communication, sensory processing, learning, memory, and synaptic plasticity.  AMPA receptors are major contributors to excitatory neurotransmission, mediate rapid, rapidly desensitizing excitation at many synapses, and are involved in early responses to glutamate in synaptic regions.  AMPA receptors are often co-expressed with NMDA receptors at synapses, and together they promote synaptic plasticity processes involved in learning, memory, excitotoxicity, and neuroprotection. Brain-derived neurotrophic factor (BDNF) is a neurotrophic factor that plays an important role in the maintenance and expansion of neurons and has powerful and numerous effects on the proliferation, differentiation, survival, and death of neuronal and non-neuronal cells. , a neurotransmitter modulator that contributes to neuronal plasticity in learning and memory. Therefore, it is essential for the health and well-being of the nervous system.

2. Feature

 (1) High purity: HBT1 can obtain high-purity products through natural extraction and refining production processes. High purity means better bioavailability and fewer adverse reactions.

 (2) Safety: HBT1 has been proven to be safe for the human body. Within the dosage range, there are no toxic side effects.

 (3) Stability: HBT1 has good stability and can maintain its activity and effect under different environments and storage conditions.

 (4) Easy to absorb: HBT1 can be quickly absorbed by the human body and distributed to different tissues and organs.

3. Application

 HBT1 is a novel AMPA receptor enhancer with low agonism, which induces the production of brain-derived neurotrophic factor (BDNF) and has minimal agonistic effects on primary neurons.  HBT1 binds to the ligand-binding domain of AMPA-R in a glutamate-dependent manner. Together, they promote synaptic plasticity processes involved in learning, memory, excitability, and neuroprotection. It can improve the brain's cognitive ability and memory, and enhance people's learning ability. It is usually added to the daily diet in the form of dietary supplements.